InvestorsHub Logo
Followers 15
Posts 1044
Boards Moderated 0
Alias Born 12/13/2017

Re: GetSeriousOK post# 328839

Sunday, 04/28/2024 7:38:40 PM

Sunday, April 28, 2024 7:38:40 PM

Post# of 330145
>>>And nobody should believe you either”<<<

I’m just the messenger. Is not the proof in the pudding? …

“BioElectronics RecoveryRx® was investigated in a double blind, randomized and placebo controlled study for postoperative pain and narcotic pain medication use following breast augmentation surgery. Data, VAS pain scores (0-10) and medication was collected for seven days post-surgery. The group using RecoveryRx® experienced 50% less pain and consumed significantly less narcotic pain medications. The study is published in the Aesthetics of Plastic Surgery.”
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174313256


Imagine that, a peer-reviewed study published in the Aesthetics of Plastic Surgery.. And you write “manipulated” data results? Do let the authors know ASAP! Be sure to put it in all CAPS as a demonstration of your scientific prowess and intellect. Yes, school the authors! Maybe they’ll laugh off that “manipulation” gem, after all, it’s coming from an anonymous message board poster. Or maybe they’ll consider it libelous.

One would think you can’t make up crap like this, but here YOU have. Keep moving the goal posts. Like one where even a 200 patients clinical trial might not be sufficient for CMS.

I dare anyone else here to post that the aforementioned study has been manipulated. As of now, YOU stand alone with this gem. Bloviating nonsense!

The NOPAIN Act and CMS Insurance reimbursement and the possibly of acceptance of BIEL’s products…it’s what for dinner everyday from now till January 1, 2025.

Like it or not!

imo